PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES
    2.
    发明申请
    PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES 有权
    包含单体的药物组合物

    公开(公告)号:US20150368173A1

    公开(公告)日:2015-12-24

    申请号:US14817286

    申请日:2015-08-04

    Abstract: The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

    Abstract translation: 本发明提供纯化大于约98.5%(w / w)的单萜或倍半萜的方法。 该方法包括衍生单萜(或倍半萜烯)以产生单萜(或倍半萜烯)衍生物,分离单萜(或倍半萜烯)衍生物和从衍生物中释放单萜(或倍半萜烯)的步骤。 包括本发明范围的药物组合物是包含纯度大于约98.5%(w / w)的单萜(或倍半萜烯)的药物组合物。 纯化的单萜可用于治疗癌症等疾病。 本单萜(或倍半萜烯)可以单独施用,或者可以与辐射或其它治疗剂如化学治疗剂共同施用。

Patent Agency Ranking